Company Filing History:
2 out of 295 
2 out of 4,126 
Years Active: 2016-2019
Title: **Debbie Mitra: A Pioneer in RNA Monomer Innovations**
Introduction
Debbie Mitra is an accomplished inventor based in Ottawa, Canada, with a notable contribution to the field of biochemistry. With two patents to her name, she has significantly advanced the development of RNA technologies, particularly through her innovative approach to RNA monomers.
Latest Patents
Mitra's latest patents focus on "RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays." This invention is directed to RNA monomers that have O-acetal levulinyl protecting groups at the 2' and/or the 5′-hydroxy functionalities of the ribose moiety. These monomers can be integrated into oligoribonucleotides or RNA polynucleotides. Her patent also outlines methods for the synthesis of these RNA monomers and their respective derivatives, as well as their deprotection processes. Notably, the compounds derived from her invention are vital for light-directed synthesis of RNA microarrays, showcasing her impact on genetic research methodologies.
Career Highlights
Throughout her career, Debbie has played a pivotal role in advancing RNA technology. She has collaborated with prestigious research institutions, including the Wisconsin Alumni Research Foundation and The Royal Institution for the Advancement of Learning/McGill University. Her focus on innovative biochemistry has enabled her to secure a reputation as a leading inventor in her field.
Collaborations
Mitra has worked alongside esteemed colleagues such as Masad Jose Damha and Jeremy Lackey. Their collective efforts in research and development have contributed to groundbreaking advancements in the understanding and application of RNA technologies, reinforcing the importance of collaboration in scientific innovation.
Conclusion
Debbie Mitra's contributions to RNA monomer research not only demonstrate her innovative spirit but also highlight the significance of her work in the scientific community. Her patents, particularly focused on RNA microarrays, represent a leap forward in biochemistry, showcasing how inventions can lead to new methodologies that enhance research in genetics and molecular biology.